Isolation and Characterization of Tetracycline-Resistant Clinical Isolates of Helicobacter pylori

Tetracycline is an important component of combination therapies for Helicobacter pylori eradication. Twenty-nine tetracycline-resistant isolates requiring MICs ranging from 4 to 16 μg/ml were isolated from Korean (22 of 460) and Japanese (7 of 105) patients. Interestingly, all of the 29 tetracycline...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Kwon, Dong H., Kim, J. J., Lee, M., Yamaoka, Y., Kato, M., Osato, M. S., El-Zaatari, F. A. K., Graham, David Y.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2000
Matèries:	Mechanisms of Resistance
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC101634/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11036054/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.11.3203-3205.2000
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!